| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2093097 | Microbiological Research | 2010 | 9 Pages |
Abstract
SummaryThe resistance genes drrABC from Streptomyces peucetius ATCC 27952 were cloned into the pIBR25 expression vector under a strong ermE* promoter to enhance doxorubicin (DXR) production. The recombinant expression plasmids, pDrrAB25, pDrrC25 and pDrrABC25, were constructed to overexpress drrAB, drrC and drrABC, respectively, in S. peucetius ATCC 27952. The recombinant strains produced more DXR than the parental strain: a 2.2-fold increase with pDrrAB25, a 5.1-fold increase with pDrrC25, and a 2.4-fold increase with pDrrABC25. We also studied the relative ratios of doxorubicin, daunorubicin and ε-rhodomycinone produced in these recombinant strains.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
Sailesh Malla, Narayan Prasad Niraula, Kwangkyoung Liou, Jae Kyung Sohng,